The research group has managed to demonstrate the good results of an algorithm that adjusts the doses of the immunosuppressant tacrolimus according to the characteristics of each person. The results have been published in the scientific journal Kidney International.
The model has been created by injecting tumor cells from a patient into a mouse to mimic the transformation of leukemia into a more aggressive form, making it possible to learn about the real evolution of the disease and be able to test new treatments.
In November, Bonpreu and Esclat clients made 185.804 donations that have made it possible to obtain 25.907€ for IDIBELL to develop new therapies for diabetes through the Solidarity Roundup, a tool developed by Worldcoo.
IDIBELL receives 25.907€ thanks to the donations of Bonpreu and Esclat customers Read More »
The World’s Top 2% Scientists ranking is published every year by Stanford University and lists around 180.000 researchers from 22 scientific fields.
30 IDIBELL researchers among the most cited scientists in the world Read More »
The three finalists have been selected from around thirty projects from Catalan hospitals or healthcare innovation centres. The prize is worth 15,000 euros and has the collaboration of IDIBELL-XarSMART.
An IDIBELL project is a finalist in the VTSO Health Innovation Award Read More »
On November 27 and 28, the first edition of the RegenBell symposium on stem cells and regenerative medicine took place, organized by IDIBELL’s Regenerative Medicine Program (RegenBell). The event was attended by more than 165 people.
The first RegenBell symposium on stem cells and regenerative medicine takes place Read More »
Based on gamification, the PAPILLOMATTACK science education project teaches what the human papillomavirus is, which diseases it causes and how it can be prevented with vaccination and screening programs
In total, 33 new basic, clinical or translational research projects of scientific excellence and social impact in the fields of study of cardiovascular diseases and infections, oncology and neurosciences will receive 25.3 million euros.
The ”la Caixa” Foundation promotes a promising study against pancreatic cancer Read More »
This improvement opens the door to more personalized therapeutic strategies and has been reflected in an article recently published in the journal Molecular Oncology.
A study by IDIBELL, ICO and IGTP puts precision medicine at the service of nerve tumors Read More »
During the XVII International Care Research Meeting, held in Valladolid between November 15 and 17, nursing professionals from the Bellvitge University Hospital (HUB) and IDIBELL researchers presented a total of four communications. One of them, led by Jordi Adamuz, won the award for the best communication of the meeting, which was organized by the Health Care and Services Research Unit (INVESTÉN) of the Carlos III Health Institute (ISCIII).
